TY  - CONF

T1  - In vivo priming with rhG-CSF increases the expression of CD33 in acute myeloid leukemia blast cells and possibly enhances the cytotoxic effect of Gemtuzumab-Ozamicin: Results of a pilot study.

JO  - BLOOD

PY  - 2003/11/16

AU  - Leone G

AU  - Rutella S

AU  - Scardocci A

AU  - Voso MT

AU  - Pagano L

ED  - 

VL  - 102

IS  - 11

SP  - 256B

EP  - 256B

Y2  - 2026/02/25

ER  -